Competitiveness of Epinogen's core technology for new drug discovery
Epinogen’s core technology for new drug discovery: discovering first-in-class new drugs with no side effects
Validating new drug targets using new concept structural platform technologies such as cryo-EM, protein design, and AI technology & possessing a drug discovery platform with no side effects
-
Identification of new drug target structure
Multi-disciplinary Structural Approaches- Supramolecular Drug Target Structure
- High-throughput Structure Determination
A platform capable of analyzing
various target proteins
and large complex structures -
New drug discovery
technology
MOA, AI Based Drug Screening
- Cryo-EM, STD-NMR, Assay Based Rational Design
- Structure-Based Assay System
MOA + Experimental base
High-Throughput Screening
and Optimization
